☑ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Puerto Rico
|
66-0555678
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
1441 F.D. Roosevelt Avenue
San Juan, Puerto Rico
|
00920
|
|
(Address of principal executive offices)
|
(Zip code)
|
Large accelerated filer
☐
|
Accelerated filer
☑
|
Non-accelerated filer
☐
|
Smaller reporting company
☐
|
Title of each class
|
Outstanding at March 31, 2017
|
Common Stock Class A, $1.00 par value
|
950,968
|
Common Stock Class B, $1.00 par value
|
23,491,670
|
Part I – Financial Information |
3
|
||
Item 1. | Financial Statements | 3 | |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 30 | |
30
|
|||
30
|
|||
31
|
|||
32
|
|||
32
|
|||
33
|
|||
35
|
|||
37
|
|||
38
|
|||
39
|
|||
Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 41 | |
Item 4. | Controls and Procedures |
41
|
|
41
|
|||
Item 1. | Legal Proceedings | 41 | |
Item 1A. | Risk Factors | 41 | |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 42 | |
Item 3. | Defaults Upon Senior Securities | 42 | |
Item 4. | Mine Safety Disclosures | 42 | |
Item 5. | Other Information | 42 | |
Item 6. | Exhibits | 42 | |
43
|
March 31,
2017
|
December 31,
2016
|
|||||||
Assets
|
||||||||
Investments and cash:
|
||||||||
Securities available for sale, at fair value:
|
||||||||
Fixed maturities
|
$
|
1,153,545
|
$
|
1,151,643
|
||||
Equity securities
|
277,149
|
270,349
|
||||||
Securities held to maturity, at amortized cost:
|
||||||||
Fixed maturities
|
2,514
|
2,836
|
||||||
Policy loans
|
8,546
|
8,564
|
||||||
Cash and cash equivalents
|
218,884
|
103,428
|
||||||
Total investments and cash
|
1,660,638
|
1,536,820
|
||||||
Premiums and other receivables, net
|
292,837
|
286,365
|
||||||
Deferred policy acquisition costs and value of business acquired
|
195,513
|
194,787
|
||||||
Property and equipment, net
|
66,756
|
66,369
|
||||||
Deferred tax asset
|
64,128
|
57,768
|
||||||
Goodwill
|
25,397
|
25,397
|
||||||
Other assets
|
53,186
|
51,493
|
||||||
Total assets
|
$
|
2,358,455
|
$
|
2,218,999
|
||||
Liabilities and Stockholders’ Equity
|
||||||||
Claim liabilities
|
$
|
530,304
|
$
|
487,943
|
||||
Liability for future policy benefits
|
326,162
|
321,232
|
||||||
Unearned premiums
|
163,780
|
79,310
|
||||||
Policyholder deposits
|
179,599
|
179,382
|
||||||
Liability to Federal Employees’ Health Benefits and Federal Employees’ Programs
|
37,206
|
34,370
|
||||||
Accounts payable and accrued liabilities
|
171,643
|
169,449
|
||||||
Deferred tax liability
|
19,599
|
18,850
|
||||||
Long-term borrowings
|
34,465
|
35,085
|
||||||
Liability for pension benefits
|
30,472
|
30,892
|
||||||
Total liabilities
|
1,493,230
|
1,356,513
|
||||||
Stockholders’ equity:
|
||||||||
Triple-S Management Corporation stockholders’ equity
|
||||||||
Common stock Class A, $1 par value. Authorized 100,000,000 shares; issued and outstanding 950,968 at March 31, 2017 and December 31, 2016, respectively
|
951
|
951
|
||||||
Common stock Class B, $1 par value. Authorized 100,000,000 shares; issued and outstanding 23,491,670 and 23,321,163 shares at March 31, 2017 and December 31, 2016, respectively
|
23,492
|
23,321
|
||||||
Additional paid-in capital
|
63,978
|
65,592
|
||||||
Retained earnings
|
726,562
|
730,904
|
||||||
Accumulated other comprehensive income
|
50,920
|
42,395
|
||||||
Total Triple-S Management Corporation stockholders’ equity
|
865,903
|
863,163
|
||||||
Non-controlling interest in consolidated subsidiary
|
(678
|
)
|
(677
|
)
|
||||
Total stockholders’ equity
|
865,225
|
862,486
|
||||||
Total liabilities and stockholders’ equity
|
$
|
2,358,455
|
$
|
2,218,999
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Revenues:
|
||||||||
Premiums earned, net
|
$
|
702,273
|
$
|
738,534
|
||||
Administrative service fees
|
4,379
|
5,083
|
||||||
Net investment income
|
12,016
|
11,358
|
||||||
Other operating revenues
|
965
|
812
|
||||||
Total operating revenues
|
719,633
|
755,787
|
||||||
Net realized investment gains on sale of securities
|
336
|
58
|
||||||
Other income, net
|
2,525
|
875
|
||||||
Total revenues
|
722,494
|
756,720
|
||||||
Benefits and expenses:
|
||||||||
Claims incurred
|
620,863
|
626,694
|
||||||
Operating expenses
|
110,946
|
122,980
|
||||||
Total operating costs
|
731,809
|
749,674
|
||||||
Interest expense
|
1,686
|
1,882
|
||||||
Total benefits and expenses
|
733,495
|
751,556
|
||||||
(Loss) income before taxes
|
(11,001
|
)
|
5,164
|
|||||
Income taxes
|
(6,658
|
)
|
1,709
|
|||||
Net (loss) income
|
(4,343
|
)
|
3,455
|
|||||
Less: Net loss attributable to non-controlling interest
|
1
|
1
|
||||||
Net (loss) income attributable to Triple-S Management Corporation
|
$
|
(4,342
|
)
|
$
|
3,456
|
|||
Earnings per share attributable to Triple-S Management Corporation
|
||||||||
Basic net (loss) income per share
|
$
|
(0.18
|
)
|
$
|
0.14
|
|||
Diluted net (loss) income per share
|
$
|
(0.18
|
)
|
$
|
0.14
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Net (loss) income
|
$
|
(4,343
|
)
|
$
|
3,455
|
|||
Other comprehensive (loss) income, net of tax:
|
||||||||
Net unrealized change in fair value of available for sale securities, net of taxes
|
8,472
|
19,577
|
||||||
Defined benefit pension plan:
|
||||||||
Actuarial loss, net
|
53
|
722
|
||||||
Prior service credit, net
|
-
|
(88
|
)
|
|||||
Total other comprehensive income, net of tax
|
8,525
|
20,211
|
||||||
Comprehensive income
|
4,182
|
23,666
|
||||||
Comprehensive income attributable to non-controlling interest
|
1
|
1
|
||||||
Comprehensive income attributable to Triple-S Management Corporation
|
$
|
4,183
|
$
|
23,667
|
2017
|
2016
|
|||||||
Balance at January 1
|
$
|
863,163
|
$
|
847,526
|
||||
Share-based compensation
|
(1,443
|
)
|
1,421
|
|||||
Repurchase and retirement of common stock
|
-
|
(8,027
|
)
|
|||||
Comprehensive income
|
4,183
|
23,667
|
||||||
Total Triple-S Management Corporation stockholders’ equity
|
865,903
|
864,587
|
||||||
Non-controlling interest in consolidated subsidiary
|
(678
|
)
|
(671
|
)
|
||||
Balance at March 31
|
$
|
865,225
|
$
|
863,916
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Cash flows from operating activities:
|
||||||||
Net (loss) income
|
$
|
(4,343
|
)
|
$
|
3,455
|
|||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Depreciation and amortization
|
2,990
|
3,700
|
||||||
Net amortization of investments
|
2,356
|
1,936
|
||||||
(Reductions) additions to the allowance for doubtful receivables
|
(3,209
|
)
|
1,531
|
|||||
Deferred tax benefit
|
(7,525
|
)
|
(2,435
|
)
|
||||
Net realized investment gain on sale of securities
|
(336
|
)
|
(58
|
)
|
||||
Interest credited to policyholder deposits
|
991
|
1,195
|
||||||
Share-based compensation
|
(1,443
|
)
|
1,085
|
|||||
(Increase) decrease in assets:
|
||||||||
Premium and other receivables, net
|
(3,263
|
)
|
(35,687
|
)
|
||||
Deferred policy acquisition costs and value of business acquired
|
(822
|
)
|
(685
|
)
|
||||
Deferred taxes
|
(265
|
)
|
162
|
|||||
Other assets
|
(37
|
)
|
(26,485
|
)
|
||||
Increase (decrease) in liabilities:
|
||||||||
Claim liabilities
|
42,361
|
33,301
|
||||||
Liability for future policy benefits
|
4,930
|
17,395
|
||||||
Unearned premiums
|
84,470
|
(4,387
|
)
|
|||||
Liability to Federal Employees’ Health Benefits and Federal Employees’ Programs
|
2,836
|
1,663
|
||||||
Accounts payable and accrued liabilities
|
11,274
|
35,574
|
||||||
Net cash provided by operating activities
|
130,965
|
31,260
|
||||||
(Continued)
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Cash flows from investing activities:
|
||||||||
Proceeds from investments sold or matured:
|
||||||||
Securities available for sale:
|
||||||||
Fixed maturities sold
|
$
|
26,023
|
$
|
90,328
|
||||
Fixed maturities matured/called
|
5,001
|
699
|
||||||
Equity securities sold
|
10,272
|
11,257
|
||||||
Securities held to maturity:
|
||||||||
Fixed maturities matured/called
|
703
|
-
|
||||||
Acquisition of investments:
|
||||||||
Securities available for sale:
|
||||||||
Fixed maturities
|
(33,738
|
)
|
(118,039
|
)
|
||||
Equity securities
|
(5,482
|
)
|
(92,956
|
)
|
||||
Securities held to maturity:
|
||||||||
Fixed maturities
|
(382
|
)
|
-
|
|||||
Increase in other investments
|
(2,044
|
)
|
(182
|
)
|
||||
Net change in policy loans
|
18
|
(231
|
)
|
|||||
Net capital expenditures
|
(3,295
|
)
|
(1,465
|
)
|
||||
Net cash used in investing activities
|
(2,924
|
)
|
(110,589
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Change in outstanding checks in excess of bank balances
|
(11,401
|
)
|
1,916
|
|||||
Repayments of long-term borrowings
|
(24,676
|
)
|
(410
|
)
|
||||
Proceeds from long-term borrowings
|
24,266
|
-
|
||||||
Repurchase and retirement of common stock
|
-
|
(8,027
|
)
|
|||||
Proceeds from policyholder deposits
|
4,116
|
3,403
|
||||||
Surrenders of policyholder deposits
|
(4,890
|
)
|
(2,905
|
)
|
||||
Net cash used in financing activities
|
(12,585
|
)
|
(6,023
|
)
|
||||
Net increase (decrease) in cash and cash equivalents
|
115,456
|
(85,352
|
)
|
|||||
Cash and cash equivalents:
|
||||||||
Beginning of period
|
103,428
|
197,818
|
||||||
End of period
|
$
|
218,884
|
$
|
112,466
|
(1) |
Basis of Presentation
|
(2) |
Recent Accounting Standards
|
(3) |
Investment in Securities
|
March 31, 2017
|
||||||||||||||||
Amortized
cost
|
Gross
unrealized
gains
|
Gross
unrealized
losses
|
Estimated
fair value
|
|||||||||||||
Securities available for sale:
|
||||||||||||||||
Fixed maturities:
|
||||||||||||||||
Obligations of government-sponsored enterprises
|
$
|
41,485
|
$
|
61
|
$
|
-
|
$
|
41,546
|
||||||||
U.S. Treasury securities and obligations of U.S. government instrumentalities
|
72,723
|
169
|
(14
|
)
|
72,878
|
|||||||||||
Obligations of the Commonwealth of Puerto Rico and its instrumentalities
|
18,248
|
857
|
(37
|
)
|
19,068
|
|||||||||||
Municipal securities
|
651,091
|
34,191
|
(304
|
)
|
684,978
|
|||||||||||
Corporate bonds
|
279,540
|
12,457
|
(367
|
)
|
291,630
|
|||||||||||
Residential mortgage-backed securities
|
638
|
29
|
-
|
667
|
||||||||||||
Collateralized mortgage obligations
|
42,919
|
83
|
(224
|
)
|
42,778
|
|||||||||||
Total fixed maturities
|
1,106,644
|
47,847
|
(946
|
)
|
1,153,545
|
|||||||||||
Equity securities - Mutual funds
|
236,356
|
40,910
|
(117
|
)
|
277,149
|
|||||||||||
Total
|
$
|
1,343,000
|
$
|
88,757
|
$
|
(1,063
|
)
|
$
|
1,430,694
|
December 31, 2016
|
||||||||||||||||
Amortized
cost
|
Gross
unrealized
gains
|
Gross
unrealized
losses
|
Estimated
fair value
|
|||||||||||||
Securities available for sale:
|
||||||||||||||||
Fixed maturities:
|
||||||||||||||||
Obligations of government-sponsored enterprises
|
$
|
41,442
|
$
|
87
|
$
|
(15
|
)
|
$
|
41,514
|
|||||||
U.S. Treasury securities and obligations of U.S. government instrumentalities
|
85,652
|
157
|
(9
|
)
|
85,800
|
|||||||||||
Obligations of the Commonwealth of Puerto Rico and its instrumentalities
|
17,930
|
2,189
|
(68
|
)
|
20,051
|
|||||||||||
Municipal securities
|
650,175
|
34,187
|
(559
|
)
|
683,803
|
|||||||||||
Corporate bonds
|
263,351
|
12,182
|
(661
|
)
|
274,872
|
|||||||||||
Residential mortgage-backed securities
|
684
|
34
|
-
|
718
|
||||||||||||
Collateralized mortgage obligations
|
45,069
|
58
|
(242
|
)
|
44,885
|
|||||||||||
Total fixed maturities
|
1,104,303
|
48,894
|
(1,554
|
)
|
1,151,643
|
|||||||||||
Equity securities - Mutual funds
|
240,699
|
30,101
|
(451
|
)
|
270,349
|
|||||||||||
Total
|
$
|
1,345,002
|
$
|
78,995
|
$
|
(2,005
|
)
|
$
|
1,421,992
|
March 31, 2017
|
||||||||||||||||
Amortized
cost
|
Gross
unrealized
gains
|
Gross
unrealized
losses
|
Estimated
fair value
|
|||||||||||||
Securities held to maturity:
|
||||||||||||||||
U.S. Treasury securities and obligations of U.S. government instrumentalities
|
$
|
619
|
$
|
160
|
$
|
-
|
$
|
779
|
||||||||
Residential mortgage-backed securities
|
191
|
18
|
-
|
209
|
||||||||||||
Certificates of deposit
|
1,704
|
-
|
-
|
1,704
|
||||||||||||
Total
|
$
|
2,514
|
$
|
178
|
$
|
-
|
$
|
2,692
|
December 31, 2016
|
||||||||||||||||
Amortized
cost
|
Gross
unrealized
gains
|
Gross
unrealized
losses
|
Estimated
fair value
|
|||||||||||||
Securities held to maturity:
|
||||||||||||||||
U.S. Treasury securities and obligations of U.S. government instrumentalities
|
$
|
619
|
$
|
158
|
$
|
-
|
$
|
777
|
||||||||
Residential mortgage-backed securities
|
191
|
18
|
-
|
209
|
||||||||||||
Certificates of deposit
|
2,026
|
-
|
-
|
2,026
|
||||||||||||
Total
|
$
|
2,836
|
$
|
176
|
$
|
-
|
$
|
3,012
|
March 31, 2017
|
||||||||||||||||||||||||||||||||||||
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||||||||||||||
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
||||||||||||||||||||||||||||
Securities available for sale
|
||||||||||||||||||||||||||||||||||||
Fixed maturities
|
||||||||||||||||||||||||||||||||||||
U.S. Treasury securities and obligations of U.S. governmental instrumentalities
|
$
|
12,940
|
$
|
(14
|
)
|
1
|
$
|
-
|
$
|
-
|
-
|
$
|
12,940
|
$
|
(14
|
)
|
1
|
|||||||||||||||||||
Obligations of the Commonwealth of Puerto Rico and its instrumentalities
|
12,704
|
(37
|
)
|
6
|
-
|
-
|
-
|
12,704
|
(37
|
)
|
6
|
|||||||||||||||||||||||||
Municipal securities
|
64,518
|
(304
|
)
|
9
|
-
|
-
|
-
|
64,518
|
(304
|
)
|
9
|
|||||||||||||||||||||||||
Corporate bonds
|
84,093
|
(367
|
)
|
18
|
-
|
-
|
-
|
84,093
|
(367
|
)
|
18
|
|||||||||||||||||||||||||
Collateralized mortgage obligations
|
26,043
|
(222
|
)
|
6
|
665
|
(2
|
)
|
1
|
26,708
|
(224
|
)
|
7
|
||||||||||||||||||||||||
Total fixed maturities
|
200,298
|
(944
|
)
|
40
|
665
|
(2
|
)
|
1
|
200,963
|
(946
|
)
|
41
|
||||||||||||||||||||||||
Equity securities-Mutual funds
|
2,831
|
(49
|
)
|
4
|
2,006
|
(68
|
)
|
1
|
4,837
|
(117
|
)
|
5
|
||||||||||||||||||||||||
Total for securities available for sale
|
$
|
203,129
|
$
|
(993
|
)
|
44
|
$
|
2,671
|
$
|
(70
|
)
|
2
|
$
|
205,800
|
$
|
(1,063
|
)
|
46
|
December 31, 2016
|
||||||||||||||||||||||||||||||||||||
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||||||||||||||
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
||||||||||||||||||||||||||||
Securites available for sale
|
||||||||||||||||||||||||||||||||||||
Fixed maturities
|
||||||||||||||||||||||||||||||||||||
Obligations of government-sponsored enterprises
|
$
|
9,483
|
$
|
(15
|
)
|
1
|
$
|
-
|
$
|
-
|
-
|
$
|
9,483
|
$
|
(15
|
)
|
1
|
|||||||||||||||||||
U.S. Treasury securities and obligations of U.S. governmental instrumentalities
|
12,937
|
(9
|
)
|
1
|
-
|
-
|
-
|
12,937
|
(9
|
)
|
1
|
|||||||||||||||||||||||||
Obligations of the Commonwealth of Puerto Rico and its instrumentalities
|
7,758
|
(68
|
)
|
5
|
-
|
-
|
-
|
7,758
|
(68
|
)
|
5
|
|||||||||||||||||||||||||
Municipal securities
|
84,252
|
(559
|
)
|
13
|
-
|
-
|
-
|
84,252
|
(559
|
)
|
13
|
|||||||||||||||||||||||||
Corporate bonds
|
105,054
|
(661
|
)
|
22
|
-
|
-
|
-
|
105,054
|
(661
|
)
|
22
|
|||||||||||||||||||||||||
Collateralized mortgage obligations
|
32,120
|
(239
|
)
|
8
|
784
|
(3
|
)
|
1
|
32,904
|
(242
|
)
|
9
|
||||||||||||||||||||||||
Total fixed maturities
|
251,604
|
(1,551
|
)
|
50
|
784
|
(3
|
)
|
1
|
252,388
|
(1,554
|
)
|
51
|
||||||||||||||||||||||||
Equity securities-Mutual funds
|
22,615
|
(451
|
)
|
4
|
-
|
-
|
-
|
22,615
|
(451
|
)
|
4
|
|||||||||||||||||||||||||
Total for securities available for sale
|
$
|
274,219
|
$
|
(2,002
|
)
|
54
|
$
|
784
|
$
|
(3
|
)
|
1
|
$
|
275,003
|
$
|
(2,005
|
)
|
55
|
March 31, 2017
|
||||||||
Amortized
cost
|
Estimated
fair value
|
|||||||
Securities available for sale:
|
||||||||
Due in one year or less
|
$
|
48,742
|
$
|
48,946
|
||||
Due after one year through five years
|
322,122
|
325,519
|
||||||
Due after five years through ten years
|
131,128
|
137,138
|
||||||
Due after ten years
|
561,095
|
598,497
|
||||||
Residential mortgage-backed securities
|
638
|
667
|
||||||
Collateralized mortgage obligations
|
42,919
|
42,778
|
||||||
$
|
1,106,644
|
$
|
1,153,545
|
|||||
Securities held to maturity:
|
||||||||
Due in one year or less
|
$
|
1,704
|
$
|
1,704
|
||||
Due after ten years
|
619
|
779
|
||||||
Residential mortgage-backed securities
|
191
|
209
|
||||||
$
|
2,514
|
$
|
2,692
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Realized gains (losses):
|
||||||||
Fixed maturity securities:
|
||||||||
Securities available for sale:
|
||||||||
Gross gains from sales
|
$
|
17
|
$
|
961
|
||||
Gross losses from sales
|
(119
|
)
|
(1,359
|
)
|
||||
Total fixed maturity securities
|
(102
|
)
|
(398
|
)
|
||||
Equity securities:
|
||||||||
Securities available for sale:
|
||||||||
Gross gains from sales
|
438
|
587
|
||||||
Gross losses from sales
|
-
|
(131
|
)
|
|||||
Total equity securities
|
438
|
456
|
||||||
Net realized gains on securities available for sale
|
$
|
336
|
$
|
58
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Changes in net unrealized gains (losses):
|
||||||||
Recognized in accumulated other comprehensive income:
|
||||||||
Fixed maturities – available for sale
|
$
|
(439
|
)
|
$
|
22,589
|
|||
Equity securities – available for sale
|
11,143
|
6,769
|
||||||
$
|
10,704
|
$
|
29,358
|
|||||
Not recognized in the consolidated financial statements:
|
||||||||
Fixed maturities – held to maturity
|
$
|
2
|
$
|
36
|
(4) |
Premiums and Other Receivables, Net
|
March 31,
2017
|
December 31,
2016
|
|||||||
Premium
|
$
|
100,691
|
$
|
91,528
|
||||
Self-funded group receivables
|
50,643
|
57,728
|
||||||
FEHBP
|
14,274
|
14,321
|
||||||
Agent balances
|
27,468
|
25,495
|
||||||
Accrued interest
|
11,338
|
13,668
|
||||||
Reinsurance recoverable
|
54,854
|
58,295
|
||||||
Other
|
65,152
|
62,637
|
||||||
324,420
|
323,672
|
|||||||
Less allowance for doubtful receivables:
|
||||||||
Premium
|
23,584
|
27,320
|
||||||
Other
|
7,999
|
9,987
|
||||||
31,583
|
37,307
|
|||||||
Total premium and other receivables, net
|
$
|
292,837
|
$
|
286,365
|
(5) |
Fair Value Measurements
|
March 31, 2017
|
||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
Securities available for sale:
|
||||||||||||||||
Fixed maturity securities
|
||||||||||||||||
Obligations of government-sponsored enterprises
|
$ | - |
$
|
41,546
|
$
|
-
|
$ | 41,546 | ||||||||
U.S. Treasury securities and obligations of U.S government instrumentalities
|
72,878
|
-
|
-
|
72,878
|
||||||||||||
Obligations of the Commonwealth of Puerto Rico and its instrumentalities
|
-
|
19,068
|
-
|
19,068
|
||||||||||||
Municipal securities
|
-
|
684,978
|
-
|
684,978
|
||||||||||||
Corporate bonds
|
-
|
291,630
|
-
|
291,630
|
||||||||||||
Residential agency mortgage-backed securities
|
-
|
667
|
-
|
667
|
||||||||||||
Collateralized mortgage obligations
|
-
|
42,778
|
-
|
42,778
|
||||||||||||
Total fixed maturities
|
72,878
|
1,080,667
|
-
|
1,153,545
|
||||||||||||
Equity securities - Mutual funds
|
174,593
|
78,803
|
23,753
|
277,149
|
||||||||||||
Total
|
$
|
247,471
|
$
|
1,159,470
|
$
|
23,753
|
$
|
1,430,694
|
December 31, 2016
|
||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
Securities available for sale:
|
||||||||||||||||
Fixed maturity securities
|
||||||||||||||||
Obligations of government-sponsored enterprises
|
$
|
-
|
$
|
41,514
|
$
|
-
|
$
|
41,514
|
||||||||
U.S. Treasury securities and obligations of U.S government instrumentalities
|
85,800
|
-
|
-
|
85,800
|
||||||||||||
Obligations of the Commonwealth of Puerto Rico and its instrumentalities
|
-
|
20,051
|
-
|
20,051
|
||||||||||||
Municipal securities
|
-
|
683,803
|
-
|
683,803
|
||||||||||||
Corporate bonds
|
-
|
274,872
|
-
|
274,872
|
||||||||||||
Residential agency mortgage-backed securities
|
-
|
718
|
-
|
718
|
||||||||||||
Collateralized mortgage obligations
|
-
|
44,885
|
-
|
44,885
|
||||||||||||
Total fixed maturities
|
85,800
|
1,065,843
|
-
|
1,151,643
|
||||||||||||
Equity securities - Mutual funds
|
166,595
|
76,222
|
27,532
|
270,349
|
||||||||||||
Total
|
$
|
252,395
|
$
|
1,142,065
|
$
|
27,532
|
$
|
1,421,992
|
Fair Value Measurements
Using Significant
Unobservable Inputs (Level 3)
|
||||||||
2017
|
2016
|
|||||||
Beginning balance
|
$
|
27,532
|
$
|
7,958
|
||||
Realized gains
|
119
|
151
|
||||||
Unrealized in other accumulated comprehensive income
|
(64
|
)
|
(649
|
)
|
||||
Purchases
|
5,260
|
8
|
||||||
Capital distributions
|
(9,094
|
)
|
(471
|
)
|
||||
Ending balance
|
$
|
23,753
|
$
|
6,997
|
March 31, 2017
|
||||||||||||||||||||
Carrying
Value
|
Fair Value
|
|||||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||||||
Assets:
|
||||||||||||||||||||
Policy loans
|
$
|
8,546
|
$
|
-
|
$
|
8,546
|
$
|
-
|
$
|
8,546
|
||||||||||
Liabilities:
|
||||||||||||||||||||
Policyholder deposits
|
$
|
179,599
|
$
|
-
|
$
|
179,599
|
$
|
-
|
$
|
179,599
|
||||||||||
Long-term borrowings:
|
||||||||||||||||||||
Loans payable to bank - variable
|
34,465
|
-
|
34,465
|
-
|
34,465
|
|||||||||||||||
Total long-term borrowings
|
34,465
|
-
|
34,465
|
-
|
34,465
|
|||||||||||||||
Total liabilities
|
$
|
214,064
|
$
|
-
|
$
|
214,064
|
$
|
-
|
$
|
214,064
|
December 31, 2016
|
||||||||||||||||||||
Carrying
Value
|
Fair Value
|
|||||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||||||
Assets:
|
||||||||||||||||||||
Policy loans
|
$
|
8,564
|
$
|
-
|
$
|
8,564
|
$
|
-
|
$
|
8,564
|
||||||||||
Liabilities:
|
||||||||||||||||||||
Policyholder deposits
|
$
|
179,382
|
$
|
-
|
$
|
179,382
|
$
|
-
|
$
|
179,382
|
||||||||||
Long-term borrowings:
|
||||||||||||||||||||
Loans payable to bank - variable
|
11,187
|
-
|
11,187
|
-
|
11,187
|
|||||||||||||||
6.6% senior unsecured notes payable
|
24,000
|
-
|
24,000
|
-
|
24,000
|
|||||||||||||||
Total long-term borrowings
|
35,187
|
-
|
35,187
|
-
|
35,187
|
|||||||||||||||
Total liabilities
|
$
|
214,569
|
$
|
-
|
$
|
214,569
|
$
|
-
|
$
|
214,569
|
(6) |
Claim Liabilities
|
Three months ended
March 31, 2017
|
||||||||||||
Managed
Care
|
Other
Business
Segments *
|
Consolidated
|
||||||||||
Claim liabilities at beginning of year
|
$
|
349,047
|
$
|
138,896
|
$
|
487,943
|
||||||
Reinsurance recoverable on claim liabilities
|
-
|
(38,998
|
)
|
(38,998
|
)
|
|||||||
Net claim liabilities at beginning of year
|
349,047
|
99,898
|
448,945
|
|||||||||
Claims incurred
|
||||||||||||
Current period insured events
|
602,620
|
28,226
|
630,846
|
|||||||||
Prior period insured events
|
(15,340
|
)
|
(1,333
|
)
|
(16,673
|
)
|
||||||
Total
|
587,280
|
26,893
|
614,173
|
|||||||||
Payments of losses and loss-adjustment expenses
|
||||||||||||
Current period insured events
|
350,450
|
7,965
|
358,415
|
|||||||||
Prior period insured events
|
192,352
|
17,945
|
210,297
|
|||||||||
Total
|
542,802
|
25,910
|
568,712
|
|||||||||
Net claim liabilities at end of year
|
393,525
|
100,881
|
494,406
|
|||||||||
Reinsurance recoverable on claim liabilities
|
-
|
35,898
|
35,898
|
|||||||||
Claim liabilities at end of year
|
$
|
393,525
|
$
|
136,779
|
$
|
530,304
|
Three months ended
March 31, 2016
|
||||||||||||
Managed
Care
|
Other
Business
Segments *
|
Consolidated
|
||||||||||
Claim liabilities at beginning of year
|
$
|
348,297
|
$
|
143,468
|
$
|
491,765
|
||||||
Reinsurance recoverable on claim liabilities
|
-
|
(40,714
|
)
|
(40,714
|
)
|
|||||||
Net claim liabilities at beginning of year
|
348,297
|
102,754
|
451,051
|
|||||||||
Claims incurred
|
||||||||||||
Current period insured events
|
614,754
|
25,890
|
640,644
|
|||||||||
Prior period insured events
|
(18,464
|
)
|
(2,248
|
)
|
(20,712
|
)
|
||||||
Total
|
596,290
|
23,642
|
619,932
|
|||||||||
Payments of losses and loss-adjustment expenses
|
||||||||||||
Current period insured events
|
365,039
|
5,096
|
370,135
|
|||||||||
Prior period insured events
|
198,100
|
17,553
|
215,653
|
|||||||||
Total
|
563,139
|
22,649
|
585,788
|
|||||||||
Net claim liabilities at end of year
|
381,448
|
103,747
|
485,195
|
|||||||||
Reinsurance recoverable on claim liabilities
|
-
|
39,871
|
39,871
|
|||||||||
Claim liabilities at end of year
|
$
|
381,448
|
$
|
143,618
|
$
|
525,066
|
* |
Other Business Segments include the Life Insurance and Property and Casualty segments, as well as intersegment eliminations.
|
Incurred
Year
|
Total of IBNR Liabilities Plus Expected
Development on Reported Claims
|
||||
2015
|
60,717
|
||||
2016
|
80,062
|
||||
2017
|
252,163
|
(7) |
Long-Term Borrowings
|
March 31,
2017
|
December 31,
2016
|
|||||||
Senior unsecured notes payable of $60,000 issued on December 2005; due December 2020. Interest is payable monthly at a fixed rate of 6.60%.
|
$
|
-
|
$
|
24,000
|
||||
Secured loan payable of $11,187, payable in monthly installments of $137 through October 1, 2023, plus interest at a rate reset periodically of 100 basis points over selected LIBOR maturity (which was 1.79% at March 31, 2017.)
|
10,777
|
11,187
|
||||||
Secured loan payable of $20,150, payable in monthly installments of $84 through January 1, 2024, plus interest at a rate reset periodically of 275 basis points over selected LIBOR maturity (which was 3.77% at March 31, 2017.)
|
19,982
|
-
|
||||||
Secured loan payable of $4,116, payable in monthly installments of $49 through January 1, 2024, plus interest at a rate reset periodically of 325 basis points over selected LIBOR maturity (which was 4.27% at March 31, 2017.)
|
4,018
|
-
|
||||||
Total borrowings
|
34,777
|
35,187
|
||||||
Less unamortized debt issuance costs
|
312
|
102
|
||||||
$
|
34,465
|
$
|
35,085
|
(8) |
Pension Plan
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Components of net periodic benefit cost:
|
||||||||
Service cost
|
$
|
-
|
$
|
1,250
|
||||
Interest cost
|
1,798
|
2,762
|
||||||
Expected return on assets
|
(2,199
|
)
|
(2,926
|
)
|
||||
Amortization of prior service benefit
|
-
|
(144
|
)
|
|||||
Amortization of actuarial loss
|
86
|
1,183
|
||||||
Net periodic benefit cost
|
$
|
(315
|
)
|
$
|
2,125
|
(9) |
Comprehensive Income
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Net Unrealized Gain on Securities Beginning Balance
|
$
|
62,371
|
$
|
62,478
|
||||
Other comprehensive income before reclassifications
|
8,741
|
19,623
|
||||||
Amounts reclassified from accumulated other comprehensive income
|
(269
|
)
|
(46
|
)
|
||||
Net current period change
|
8,472
|
19,577
|
||||||
Ending Balance
|
70,843
|
82,055
|
||||||
Liability for Pension Benefits Beginning Balance
|
(19,976
|
)
|
(36,855
|
)
|
||||
Amounts reclassified from accumulated other comprehensive income
|
53
|
634
|
||||||
Ending Balance
|
(19,923
|
)
|
(36,221
|
)
|
||||
Accumulated Other Comprehensive Income Beginning Balance
|
42,395
|
25,623
|
||||||
Other comprehensive income before reclassifications
|
8,741
|
19,623
|
||||||
Amounts reclassified from accumulated other comprehensive income
|
(216
|
)
|
588
|
|||||
Net current period change
|
8,525
|
20,211
|
||||||
Ending Balance
|
$
|
50,920
|
$
|
45,834
|
(10) |
Share-Based Compensation
|
(11) |
Net Income Available to Stockholders and Net Income per Share
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Numerator for earnings per share:
|
||||||||
Net (loss) income attributable to TSM available to stockholders
|
$
|
(4,342
|
)
|
$
|
3,456
|
|||
Denominator for basic earnings per share:
|
||||||||
Weighted average of common shares
|
24,143,261
|
24,587,681
|
||||||
Effect of dilutive securities
|
-
|
72,353
|
||||||
Denominator for diluted earnings per share
|
24,143,261
|
24,660,034
|
||||||
Basic net (loss) income per share attributable to TSM
|
$
|
(0.18
|
)
|
$
|
0.14
|
|||
Diluted net (loss) income per share attributable to TSM
|
$
|
(0.18
|
)
|
$
|
0.14
|
(12) |
Contingencies
|
(13) |
Segment Information
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Operating revenues:
|
||||||||
Managed Care:
|
||||||||
Premiums earned, net
|
$
|
640,147
|
$
|
678,380
|
||||
Administrative service fees
|
4,379
|
5,083
|
||||||
Intersegment premiums/service fees
|
1,534
|
1,485
|
||||||
Net investment income
|
3,892
|
3,480
|
||||||
Total managed care
|
649,952
|
688,428
|
||||||
Life Insurance:
|
||||||||
Premiums earned, net
|
40,298
|
38,966
|
||||||
Intersegment premiums
|
191
|
137
|
||||||
Net investment income
|
6,087
|
5,914
|
||||||
Total life insurance
|
46,576
|
45,017
|
||||||
Property and Casualty Insurance:
|
||||||||
Premiums earned, net
|
21,548
|
21,188
|
||||||
Intersegment premiums
|
153
|
153
|
||||||
Net investment income
|
1,924
|
1,929
|
||||||
Total property and casualty insurance
|
23,625
|
23,270
|
||||||
Other segments: *
|
||||||||
Intersegment service revenues
|
1,586
|
2,545
|
||||||
Operating revenues from external sources
|
1,000
|
856
|
||||||
Total other segments
|
2,586
|
3,401
|
||||||
Total business segments
|
722,739
|
760,116
|
||||||
TSM operating revenues from external sources
|
78
|
4
|
||||||
Elimination of intersegment premiums/service fees
|
(1,598
|
)
|
(1,775
|
)
|
||||
Elimination of intersegment service revenues
|
(1,586
|
)
|
(2,545
|
)
|
||||
Other intersegment eliminations
|
-
|
(13
|
)
|
|||||
Consolidated operating revenues
|
$
|
719,633
|
$
|
755,787
|
* |
Includes segments that are not required to be reported separately, primarily the data processing services organization and the health clinic.
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Operating income (loss):
|
||||||||
Managed care
|
$
|
(18,582
|
)
|
$
|
(641
|
)
|
||
Life insurance
|
3,935
|
5,598
|
||||||
Property and casualty insurance
|
2,067
|
2,111
|
||||||
Other segments *
|
143
|
(179
|
)
|
|||||
Total business segments
|
(12,437
|
)
|
6,889
|
|||||
TSM operating revenues from external sources
|
78
|
4
|
||||||
TSM unallocated operating expenses
|
(2,217
|
)
|
(3,167
|
)
|
||||
Elimination of TSM intersegment charges
|
2,400
|
2,387
|
||||||
Consolidated operating (loss) income
|
(12,176
|
)
|
6,113
|
|||||
Consolidated net realized investment gains
|
336
|
58
|
||||||
Consolidated interest expense
|
(1,686
|
)
|
(1,882
|
)
|
||||
Consolidated other income, net
|
2,525
|
875
|
||||||
Consolidated (loss) income before taxes
|
$
|
(11,001
|
)
|
$
|
5,164
|
|||
Depreciation and amortization expense:
|
||||||||
Managed care
|
$
|
2,239
|
$
|
2,934
|
||||
Life insurance
|
280
|
255
|
||||||
Property and casualty insurance
|
114
|
161
|
||||||
Other segments*
|
160
|
153
|
||||||
Total business segments
|
2,793
|
3,503
|
||||||
TSM depreciation expense
|
197
|
197
|
||||||
Consolidated depreciation and amortization expense
|
$
|
2,990
|
$
|
3,700
|
* |
Includes segments that are not required to be reported separately, primarily the data processing services organization and the health clinic.
|
March 31,
2017
|
December 31,
2016
|
|||||||
Assets:
|
||||||||
Managed care
|
$
|
1,144,927
|
$
|
1,013,872
|
||||
Life insurance
|
820,481
|
816,920
|
||||||
Property and casualty insurance
|
347,282
|
349,159
|
||||||
Other segments *
|
26,274
|
26,034
|
||||||
Total business segments
|
2,338,964
|
2,205,985
|
||||||
Unallocated amounts related to TSM:
|
||||||||
Cash, cash equivalents, and investments
|
22,531
|
17,033
|
||||||
Property and equipment, net
|
22,228
|
22,380
|
||||||
Other assets
|
21,337
|
21,646
|
||||||
66,096
|
61,059
|
|||||||
Elimination entries-intersegment receivables and others
|
(46,605
|
)
|
(48,045
|
)
|
||||
Consolidated total assets
|
$
|
2,358,455
|
$
|
2,218,999
|
* |
Includes segments that are not required to be reported separately, primarily the data processing services organization and the health clinic.
|
(14) |
Subsequent Events
|
As of March 31,
|
||||||||
2017
|
2016
|
|||||||
Managed care enrollment:
|
||||||||
Commercial
1
|
505,848
|
544,846
|
||||||
Medicare
|
121,352
|
119,224
|
||||||
Medicaid
|
389,130
|
402,933
|
||||||
Total
|
1,016,330
|
1,067,003
|
||||||
Managed care enrollment by funding arrangement:
|
||||||||
Fully-insured
|
847,327
|
886,547
|
||||||
Self-insured
|
169,003
|
180,456
|
||||||
Total
|
1,016,330
|
1,067,003
|
(1) |
Commercial membership includes corporate accounts, self-funded employers, individual accounts, Medicare Supplement, Federal government employees and local government employees.
|
Three months ended
March 31,
|
||||||||
(dollar amounts in millions)
|
2017
|
2016
|
||||||
Revenues:
|
||||||||
Premiums earned, net
|
$
|
702.3
|
$
|
738.5
|
||||
Administrative service fees
|
4.4
|
5.1
|
||||||
Net investment income
|
12.0
|
11.4
|
||||||
Other operating revenues
|
0.9
|
0.8
|
||||||
Total operating revenues
|
719.6
|
755.8
|
||||||
Net realized investment gains
|
0.3
|
-
|
||||||
Other income, net
|
2.6
|
0.9
|
||||||
Total revenues
|
722.5
|
756.7
|
||||||
Benefits and expenses:
|
||||||||
Claims incurred
|
620.9
|
626.7
|
||||||
Operating expenses
|
110.9
|
123.0
|
||||||
Total operating expenses
|
731.8
|
749.7
|
||||||
Interest expense
|
1.7
|
1.9
|
||||||
Total benefits and expenses
|
733.5
|
751.6
|
||||||
(Loss) income before taxes
|
(11.0
|
)
|
5.1
|
|||||
Income taxes (benefit) / expense
|
(6.7
|
)
|
1.7
|
|||||
Net (loss) income attributable to TSM
|
$
|
(4.3
|
)
|
$
|
3.4
|
Three months ended
March 31,
|
||||||||
(dollar amounts in millions)
|
2017
|
2016
|
||||||
Operating revenues:
|
||||||||
Medical premiums earned, net:
|
||||||||
Commercial
|
$
|
205.1
|
$
|
215.5
|
||||
Medicare
|
257.7
|
261.0
|
||||||
Medicaid
|
177.7
|
202.2
|
||||||
Medical premiums earned, net
|
640.5
|
678.7
|
||||||
Administrative service fees
|
5.6
|
6.3
|
||||||
Net investment income
|
3.9
|
3.5
|
||||||
Total operating revenues
|
650.0
|
688.5
|
||||||
Medical operating costs:
|
||||||||
Medical claims incurred
|
587.3
|
596.3
|
||||||
Medical operating expenses
|
81.3
|
92.8
|
||||||
Total medical operating costs
|
668.6
|
689.1
|
||||||
Medical operating loss
|
$
|
(18.6
|
)
|
$
|
(0.6
|
)
|
||
Additional data:
|
||||||||
Member months enrollment:
|
||||||||
Commercial:
|
||||||||
Fully-insured
|
1,013,205
|
1,096,282
|
||||||
Self-funded
|
507,167
|
543,026
|
||||||
Total Commercial
|
1,520,372
|
1,639,308
|
||||||
Medicare
|
363,727
|
364,427
|
||||||
Medicaid
|
1,173,273
|
1,221,892
|
||||||
Total member months
|
3,057,372
|
3,225,627
|
||||||
Medical loss ratio
|
91.7
|
%
|
87.9
|
%
|
||||
Operating expense ratio
|
12.6
|
%
|
13.5
|
%
|
• |
Medical premiums generated by the Medicaid business amounted to $177.7 million, $24.5 million, or 12.1% lower when compared to the medical premiums earned during the three months ended March 31, 2016. Decrease primarily reflects lower fully-insured member months enrollment by approximately 48,600 lives and the 4% decrease in average premium rates that went into effect July 1, 2016. Also contributing to the lower premiums during this period are last year’s partial reversal of the accrued 2.5% excess profit of $3.6 million and to $2.6 million related to the suspension of the HIP fee pass-through as a result of the 2017 moratorium.
|
• |
Medical premiums generated by the Commercial business decreased by $10.4 million, or 4.8%, to $205.1 million. This fluctuation primarily reflects lower fully-insured member enrollment during the quarter of approximately 83,000 member months and $3.5 million related to the suspension of the HIP fee pass-through; offset by an increase in average premium rates of approximately 5%.
|
• |
Medical premiums generated by the Medicare business decreased by $3.3 million, or 1.3%, to $257.7 million, primarily reflecting lower average premium rates due to a change in membership mix, with the current period presenting a higher concentration of non-dual individuals and groups and a reduction in the 2017 Medicare reimbursement rates.
|
• |
The medical claims incurred in the Medicaid business decreased by $8.4 million, or 4.6%, during the 2017 period, mostly driven by lower enrollment offset by higher utilization. The MLR, at 97.8%, was 770 basis point higher than the same period last year. The higher MLR primarily reflects increased pharmacy and outpatient claim trends and the lower premium rates that went into effect July 1, 2016.
|
• |
The medical claims incurred of the Commercial business decreased by $7.6 million, or 4.3%, during the 2017 period mostly driven by lower enrollment. The MLR, at 83.5%, was 70 basis point higher than the same month last year. Adjusting for the effect of prior period reserve developments, the Commercial MLR would have been 83.3%, 240 basis points lower than the adjusted MLR for last year primarily reflecting claim trends that are lower than our premium trends following the continuity of our underwriting discipline.
|
• |
The medical claims incurred of the Medicare business increased by $7.0 million, or 3.0%, during the 2017 period and its MLR increased by 390 basis points, to 94.0%. Adjusting for the effect of prior period reserve developments in 2017 and 2016 and moving the risk score revenue adjustments to their corresponding period, the Medicare MLR would have been approximately 95.6% this quarter, about 280 basis points higher than last year, primarily reflecting higher trends in Part B drugs, pharmacy benefits and the improvement of benefits in 2017 products taking advantage of the HIP fee moratorium.
|
Three months ended
March 31,
|
||||||||
(dollar amounts in millions)
|
2017
|
2016
|
||||||
Operating revenues:
|
||||||||
Premiums earned, net:
|
||||||||
Premiums earned
|
$
|
41.8
|
$
|
39.8
|
||||
Assumed earned premiums
|
0.9
|
1.5
|
||||||
Ceded premiums earned
|
(2.2
|
)
|
(2.2
|
)
|
||||
Premiums earned, net
|
40.5
|
39.1
|
||||||
Net investment income
|
6.1
|
5.9
|
||||||
Total operating revenues
|
46.6
|
45.0
|
||||||
Operating costs:
|
||||||||
Policy benefits and claims incurred
|
23.7
|
21.4
|
||||||
Underwriting and other expenses
|
19.0
|
18.0
|
||||||
Total operating costs
|
42.7
|
39.4
|
||||||
Operating income
|
$
|
3.9
|
$
|
5.6
|
||||
Additional data:
|
||||||||
Loss ratio
|
58.5
|
%
|
54.7
|
%
|
||||
Operating expense ratio
|
46.9
|
%
|
46.0
|
%
|
Three months ended
March 31,
|
||||||||
(dollar amounts in millions)
|
2017
|
2016
|
||||||
Operating revenues:
|
||||||||
Premiums earned, net:
|
||||||||
Premiums written
|
$
|
27.4
|
$
|
27.6
|
||||
Premiums ceded
|
(10.1
|
)
|
(10.4
|
)
|
||||
Change in unearned premiums
|
4.4
|
4.1
|
||||||
Premiums earned, net
|
21.7
|
21.3
|
||||||
Net investment income
|
1.9
|
1.9
|
||||||
Total operating revenues
|
23.6
|
23.2
|
||||||
Operating costs:
|
||||||||
Claims incurred
|
10.6
|
9.7
|
||||||
Underwriting and other expenses
|
10.9
|
11.4
|
||||||
Total operating costs
|
21.5
|
21.1
|
||||||
Operating income
|
$
|
2.1
|
$
|
2.1
|
||||
Additional data:
|
||||||||
Loss ratio
|
48.8
|
%
|
45.5
|
%
|
||||
Operating expense ratio
|
50.2
|
%
|
53.5
|
%
|
Three months ended
March 31,
|
||||||||
(dollar amounts in millions)
|
2017
|
2016
|
||||||
Sources (uses) of cash:
|
||||||||
Cash provided by operating activities
|
$
|
131.0
|
$
|
31.3
|
||||
Net proceeds (purchases) of investment securities
|
0.4
|
(108.9
|
)
|
|||||
Net capital expenditures
|
(3.3
|
)
|
(1.5
|
)
|
||||
Proceeds from long-term borrowings
|
24.3
|
-
|
||||||
Payments of long-term borrowings
|
(24.7
|
)
|
(0.4
|
)
|
||||
Proceeds from policyholder deposits
|
4.1
|
3.4
|
||||||
Surrenders of policyholder deposits
|
(4.9
|
)
|
(2.9
|
)
|
||||
Repurchase and retirement of common stock
|
-
|
(8.0
|
)
|
|||||
Other
|
(11.4
|
)
|
1.6
|
|||||
Net increase (decrease) in cash and cash equivalents
|
$
|
115.5
|
$
|
(85.4
|
)
|
Item 1A. |
Risk Factors
|
Exhibits
|
Description
|
3(i)(c)
|
Articles of Incorporation of Triple-S Management Corporation, incorporated by reference to Exhibit 3(i)(c) to TSM’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2008 (File No. 001-33865).
|
Amendments to Article Tenth and Thirteenth of the Amended and Restated Articles of Incorporation of Triple-S Management Corporation.
|
|
Composite Amended and Restated Articles of Incorporation of Triple-S Management Corporation.
|
|
11
|
Statement re computation of per share earnings; an exhibit describing the computation of the earnings per share for the three months ended March 31, 2017 and 2016 has been omitted as the detail necessary to determine the computation of earnings per share can be clearly determined from the material contained in Part I of this Quarterly Report on Form 10-Q.
|
Certification of the President and Chief Executive Officer required by Rule 13a-14(a)/15d-14(a).
|
|
Certification of the Executive Vice President and Chief Financial Officer required by Rule 13a-14(a)/15d-14(a).
|
|
Certification of the President and Chief Executive Officer required pursuant to 18 U.S.C Section 1350.
|
|
Certification of the Executive Vice President and Chief Financial Officer required pursuant to 18 U.S.C Section 1350.
|
* |
Filed herein.
|
Triple-S Management Corporation
|
|||||
Registrant
|
|||||
Date:
|
May 9, 2017
|
By:
|
/s/
Roberto García-Rodríguez
|
||
Roberto García-Rodríguez
|
|||||
President and Chief Executive Officer
|
|||||
Date:
|
May 9, 2017
|
By:
|
/s/
Juan J. Román-Jiménez
|
||
Juan J. Román-Jiménez
|
|||||
Executive Vice President and Chief Financial Officer
|
/s/ Daniel E. Gonzàlez-Ortiz
|
|
Daniel E. Gonzàlez-Ortiz
|
|
Assistant Corporate Secretary
|
FIRST: ` |
The name of this corporation is
TRIPLE-S MANAGEMENT CORPORATION
.
|
SECOND: |
The physical address of the designated office of the Corporation is 1441 F.D. Roosevelt Avenue, San Juan, Puerto Rico 00920.
|
THIRD: |
The Corporation’s registered agent will be the Corporation itself, Triple-S Management Corporation. The address of such resident agent is 1441 F.D. Roosevelt Avenue, San Juan, Puerto Rico 00920.
|
FOURTH: |
The nature of the business or purposes to be conducted or promoted by the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the Commonwealth of Puerto Rico, as from time to time amended (the “GCLPR”).
|
FIFTH: |
A. The total number of shares of all classes of stock which the Corporation shall have authority to issue is Three Hundred Million (300,000,000) shares, consisting of (a)(1) one hundred million (100,000,000) shares of Class A Common Stock, par value $1.00 per share (the “Class A Common Stock”), and (2) one hundred million (100,000,000) shares of Class B Common Stock, par value $1.00 per share (the “Class B Common Stock”), and (b) One Hundred Million (100,000,000) shares of Preferred Stock, par value $1.00 per share (the “Preferred Stock”). On the effective date of this provision, all shares of common stock outstanding prior thereto shall be automatically converted into Class A Common Stock. As used herein the term “Common Stock” shall mean the Class A Common Stock and Class B Common Stock. The rights, privileges and ownership interests represented by each share of Class A Common Stock shall be identical in every respect to the rights, privileges and ownership interests represented by each share of Class B Common Stock, except as otherwise expressly provided below.
|
SIXTH: |
The shares of capital stock of the Corporation shall be subject to the transfer restrictions set forth in
Attachment A
to these Articles of Incorporation. Such transfer restrictions are being adopted in order for the Corporation to comply with the License Agreement between Blue Cross and Blue Shield Association (or its then successor) (the “BCBSA”) and the Corporation and related License Agreements between the subsidiaries of the Corporation and BCBSA.
|
SEVENTH: |
A. At every annual or special meeting of shareholders of the Corporation, every holder of shares of Common Stock shall be entitled to one (1) vote for each share of Common Stock standing in his or her name on the books of the Corporation.
|
EIGHTH: |
A. The Corporation shall be required, to the maximum extent permitted by the GCLPR, to indemnify each of its directors, officers and employees and any director, officer or employee who is or was serving at the request of the Corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, limited liability company or other enterprise against expenses, judgments, fines, settlements, and other amounts actually and reasonably incurred in connection with any proceeding arising due to the fact that any such person is or was a director, an officer or an employee of the Corporation or is or was serving at the request of the Corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, limited liability company or other enterprise.
|
NINTH: |
A director of the Corporation shall not be personally liable to the Corporation or its shareholders for monetary damages for breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under the GCLPR. In no event shall any director be deemed to breach any fiduciary duty or other obligation owed to any shareholders of the Corporation or any other person by reason of (i) his or her failure to vote for (or by reason of such director’s vote against) any proposal or course of action that in such director’s judgment would breach any requirement imposed on the Corporation or any subsidiary or affiliate of the Corporation by the BCBSA or could lead to termination of any license granted by the BCBSA to the Corporation or any subsidiary or affiliate of the Corporation, or (ii) his or her decision to vote in favor of any proposal or course of action that in such director’s judgment is necessary to prevent a breach of any requirement imposed by the BCBSA or could prevent termination of any license granted by the BCBSA to the Corporation or any subsidiary or affiliate of the Corporation. Any repeal or modification of the foregoing provisions of this Article NINTH by the shareholders of the Corporation shall not adversely affect any right or protection of a director of the Corporation existing at the time of such repeal or modification.
|
A. |
The business and affairs of the Corporation shall be managed under the direction of a Board of Directors consisting of not less than seven (7) Directors, nor more than thirteen (13) Directors.
|
B. |
Subject to the terms of this paragraph, the Board of Directors shall be divided into three groups, respectively designated “Group 1,” “Group 2,” and “Group 3,” as nearly equal in number as possible and whose term expire at different times. Directors in each group shall be elected for a term ending on the date of the third annual meeting of shareholders following the annual meeting at which such director is elected. The Board of Directors may (i) reduce the size of each group of directors and (ii) nominate directors for shorter terms of office and assign such nominees to another group, in order to meet the requirements of the first sentence of this paragraph by the 2010 annual meeting of shareholders.
|
C. |
Every director will perform his/her duties until his/her successor is duly elected and in possession of his/her position.
|
ELEVENTH:
|
The Corporation will exist in perpetuity.
|
i. |
in respect of a claim against the Corporation under any share acquisition agreement; or
|
ii. |
to any purported non-medical heir of a former shareholder of the Corporation or any of its predecessor entities or any of the predecessor entities of TSI which holder’s shares of common stock or common stock of any of the Corporation’s predecessor entities or the predecessor entities of TSI were cancelled following the holder’s death in respect of any purported right of such heir to receive, by way of testate or intestate transfer or otherwise, the shares of common stock or such common stock owned by such shareholder at the time of his or her death.
|
DR
|
=
|
(CAO + X)
|
||
(CAO + Y)
|
X
|
=
|
OA (MC – VA)
|
||
OB (VA – VO)
|
1. |
I have reviewed this quarterly report on Form 10-Q of Triple-S Management Corporation;
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4. |
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c. |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d. |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5. |
The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
May 9, 2017
|
By:
|
/s/
Roberto García-Rodríguez
|
||
Roberto García-Rodríguez
|
|||||
President and Chief Executive Officer
|
1. |
I have reviewed this quarterly report on Form 10-Q of Triple-S Management Corporation;
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4. |
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5. |
The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
May 9, 2017
|
By:
|
/s/
Juan J. Román-Jiménez
|
||
Juan J. Román-Jiménez
|
|||||
Executive Vice President and Chief Financial Officer
|
a) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
b) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
May 9, 2017
|
By:
|
/s/
Roberto García-Rodríguez
|
||
Roberto García-Rodríguez
|
|||||
President and Chief Executive Officer
|
a) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
b) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
May 9, 2017
|
By:
|
/s/
Juan J. Román-Jiménez
|
||
Juan J. Román-Jiménez
|
|||||
Executive Vice President and Chief Financial Officer
|